In a new step forward on the quest for better painkillers, scientists have developed a synthetic cannabinoid that keeps the ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

When it comes to cannabis compounds, THC and CBD get top billing, but they are just two of over 100 chemicals known as ...

Cannabinoid-induced poisonings are leading to more hospital admissions as drug traffickers target puff bars, gummies, and e-cigarettes.

A survey of individuals with cannabinoid hyperemesis syndrome reveals high rates of emergency care and hospitalizations, with ...

A new study analyzes the disease burden and the risk factors for severity among people who suffer from a condition called cannabinoid hyperemesis syndrome. Researchers at the George Washington ...

In a collaboration between Washington University School of Medicine in St. Louis and Stanford University, researchers have developed a cannabinoid compound that provides pain relief without the ...

Discover how cannabinoid receptor type 1 (CB1) influences resilience to stress and its potential in treating anxiety and ...

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...